Study for Yimaxin for luteal phase support in assisted reproduction

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027963

Enrollment

Unknown

Registered

2019-12-07

Start date

2019-12-04

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fmale infertility

Interventions

Ovulation cycle group:A1 Dydrogesterone10mg/bid +A2 Yimaxin100mg/bid +A3 Yimaxin100mg/tid

Anovulation cycle Group:B1 crinone90mg/qd + B2 Yimaxin100mg/tid + B3 Yimaxin200mg/bid

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patient 20-40 years; 2. FSH<15IU/L; 3. BMI<25.

Exclusion criteria

Exclusion criteria: 1.>=3 transplants without previous clinical pregnancy; 2. Patient with uterine cavity abnormalities; 3. Patient with recurrent miscarriage; 4. Abnormal liver or thyroid function or hyperlactinemia or with past neurological disorder hypertension; 5. People allergic to research drugs; 6. A people with chromosomal abnormality on both side.

Design outcomes

Primary

Measure	Time frame
Pregnancy;	—

Countries

China

Contacts

Public ContactJunli Zhao

Ningxia Medical university

zhaojunli6812@163.com+86 13909519609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026